Position | Company | Period |
---|
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
12.805
-40.2%
0,678.618 USD |
12.805 -40.2% | 0,67 | 8.618 USD | |
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.309
-40.5%
0,673.573 USD |
5.309 -40.5% | 0,67 | 3.573 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.220
-39.9%
0,854.458 USD |
5.220 -39.9% | 0,85 | 4.458 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.009
-39.6%
0,843.354 USD |
4.009 -39.6% | 0,84 | 3.354 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.440
-37.9%
1,868.250 USD |
4.440 -37.9% | 1,86 | 8.250 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.100
-38.9%
1,691.863 USD |
1.100 -38.9% | 1,69 | 1.863 USD | |
2022-08-01 | 2022-08-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.983
-38.2%
1,775.290 USD |
2.983 -38.2% | 1,77 | 5.290 USD | |
2022-07-05 | 2022-07-05 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.973
-38.9%
1,683.311 USD |
1.973 -38.9% | 1,68 | 3.311 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.368
-37.3%
3,1913.942 USD |
4.368 -37.3% | 3,19 | 13.942 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.076
-38.1%
3,543.813 USD |
1.076 -38.1% | 3,54 | 3.813 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.770
-37.3%
3,5613.409 USD |
3.770 -37.3% | 3,56 | 13.409 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.070
-37.9%
4,064.349 USD |
1.070 -37.9% | 4,06 | 4.349 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.358
-37.2%
5,6724.708 USD |
4.358 -37.2% | 5,67 | 24.708 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.058
-37.5%
6,156.509 USD |
1.058 -37.5% | 6,15 | 6.509 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.065
-37.7%
5,335.674 USD |
1.065 -37.7% | 5,33 | 5.674 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.823
-37.4%
9,2544.613 USD |
4.823 -37.4% | 9,25 | 44.613 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.144
-40.5%
5,135.874 USD |
1.144 -40.5% | 5,13 | 5.874 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
1.148
-40.6%
1,201.378 USD |
1.148 -40.6% | 1,20 | 1.378 USD |